{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:13:35Z","timestamp":1707524015789},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,1]]},"DOI":"10.7759\/cureus.44530","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T14:21:51Z","timestamp":1693578111000},"source":"Crossref","is-referenced-by-count":0,"title":["Drug-Resistant Parkinson\u2019s Disease in a Patient With Hereditary Hemochromatosis: A Case Report"],"prefix":"10.7759","author":[{"given":"Conor W","family":"Banta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Zonna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Lott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Jaisawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amr","family":"Elsisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70117-6","article-title":"The role of iron in brain ageing and neurodegenerative disorders","volume":"13","author":"Ward RJ","year":"2014","unstructured":"Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L. The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol. 2014, 13:1045-60. 10.1016\/S1474-4422(14)70117-6","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1021\/tx700210j","article-title":"Oxidative stress and neurotoxicity","volume":"21","author":"Sayre LM","year":"2008","unstructured":"Sayre LM, Perry G, Smith MA. Oxidative stress and neurotoxicity. Chem Res Toxicol. 2008, 21:172-88. 10.1021\/tx700210j","journal-title":"Chem Res Toxicol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.45.6.1138","article-title":"Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease","volume":"45","author":"Gorell JM","year":"1995","unstructured":"Gorell JM, Ordidge RJ, Brown GG, Deniau JC, Buderer NM, Helpern JA. Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease. Neurology. 1995, 45:1138-43. 10.1212\/wnl.45.6.1138","journal-title":"Neurology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12862-x","article-title":"\u03b1-Synuclein impairs ferritinophagy in the retinal pigment epithelium: implications for retinal iron dyshomeostasis in Parkinson's disease","volume":"7","author":"Baksi S","year":"2017","unstructured":"Baksi S, Singh N. \u03b1-Synuclein impairs ferritinophagy in the retinal pigment epithelium: implications for retinal iron dyshomeostasis in Parkinson's disease. Sci Rep. 2017, 7:12843. 10.1038\/s41598-017-12862-x","journal-title":"Sci Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1006\/bcmd.1996.0027","article-title":"Mutation analysis in hereditary hemochromatosis","volume":"22","author":"Beutler E","year":"1996","unstructured":"Beutler E, Gelbart T, West C, et al.. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis. 1996, 22:187-94; discussion 194a-194b. 10.1006\/bcmd.1996.0027","journal-title":"Blood Cells Mol Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/jcag\/gwac025","article-title":"C282Y\/H63D compound heterozygosity is a low penetrance genotype for iron overload-related disease","volume":"5","author":"Hasan SM","year":"2022","unstructured":"Hasan SM, Farrell J, Borgaonkar M. C282Y\/H63D compound heterozygosity is a low penetrance genotype for iron overload-related disease. J Can Assoc Gastroenterol. 2022, 5:240-7. 10.1093\/jcag\/gwac025","journal-title":"J Can Assoc Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.17.2216","article-title":"Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States","volume":"285","author":"Steinberg KK","year":"2001","unstructured":"Steinberg KK, Cogswell ME, Chang JC, et al.. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. JAMA. 2001, 285:2216-22. 10.1001\/jama.285.17.2216","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22972","article-title":"HFE C282Y\/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity","volume":"50","author":"Gurrin LC","year":"2009","unstructured":"Gurrin LC, Bertalli NA, Dalton GW, et al.. HFE C282Y\/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity. Hepatology. 2009, 50:94-101. 10.1002\/hep.22972","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2003.027441","article-title":"Concurrent hereditary haemochromatosis and idiopathic Parkinson's disease: a case report series","volume":"75","author":"Costello DJ","year":"2004","unstructured":"Costello DJ, Walsh SL, Harrington HJ, Walsh CH. Concurrent hereditary haemochromatosis and idiopathic Parkinson's disease: a case report series. J Neurol Neurosurg Psychiatry. 2004, 75:631-3. 10.1136\/jnnp.2003.027441","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3940(03)00713-4","article-title":"Mutations in the hemochromatosis gene (HFE), Parkinson's disease and parkinsonism","volume":"348","author":"Dekker MC","year":"2003","unstructured":"Dekker MC, Giesbergen PC, Njajou OT, van Swieten JC, Hofman A, Breteler MM, van Duijn CM. Mutations in the hemochromatosis gene (HFE), Parkinson's disease and parkinsonism. Neurosci Lett. 2003, 348:117-9. 10.1016\/s0304-3940(03)00713-4","journal-title":"Neurosci Lett"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-6-24","article-title":"Association of HFE common mutations with Parkinson's disease, Alzheimer's disease and mild cognitive impairment in a Portuguese cohort","volume":"6","author":"Guerreiro RJ","year":"2006","unstructured":"Guerreiro RJ, Bras JM, Santana I, et al.. Association of HFE common mutations with Parkinson's disease, Alzheimer's disease and mild cognitive impairment in a Portuguese cohort. BMC Neurol. 2006, 6:24. 10.1186\/1471-2377-6-24","journal-title":"BMC Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci8110194","article-title":"Parkinson\u2019s disease and metal storage disorders: a systematic review","volume":"8","author":"Botsford E","year":"2018","unstructured":"Botsford E, George J, Buckley EE. Parkinson\u2019s disease and metal storage disorders: a systematic review. Brain Sci. 2018, 8:194. 10.3390\/brainsci8110194","journal-title":"Brain Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2008.12.001","article-title":"Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases","volume":"1790","author":"Cahill CM","year":"2009","unstructured":"Cahill CM, Lahiri DK, Huang X, Rogers JT. Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases. Biochim Biophys Acta. 2009, 1790:615-28. 10.1016\/j.bbagen.2008.12.001","journal-title":"Biochim Biophys Acta"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2013.5593","article-title":"Targeting chelatable iron as a therapeutic modality in Parkinson's disease","volume":"21","author":"Devos D","year":"2014","unstructured":"Devos D, Moreau C, Devedjian JC, et al.. Targeting chelatable iron as a therapeutic modality in Parkinson's disease. Antioxid Redox Signal. 2014, 21:195-210. 10.1089\/ars.2013.5593","journal-title":"Antioxid Redox Signal"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/178918-drug-resistant-parkinsons-disease-in-a-patient-with-hereditary-hemochromatosis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:40Z","timestamp":1707508720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/178918-drug-resistant-parkinsons-disease-in-a-patient-with-hereditary-hemochromatosis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.44530","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,1]]}}}